Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling
The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
25.04.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes. |
|---|---|
| AbstractList | The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes. |
| Author | Jessop, Theodore Curtis Chen, Zhaogen Bleisch, Thomas John |
| Author_xml | – fullname: Jessop, Theodore Curtis – fullname: Chen, Zhaogen – fullname: Bleisch, Thomas John |
| BookMark | eNrjYmDJy89L5WTwCS5NKi7JLCktSU1RKKgsSqzKz8mPNtQx1U2MBXIzczNTMvNSixUSixUy8zIykzJL8ouKFfLTgLyS1KK01KL8PIXizPS8xJzMvHQeBta0xJziVF4ozc2g6OYa4uyhm1qQH59aXJCYnJqXWhIfGmxoaGZsYmJk7GRkTIwaABtbOFY |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US11634423B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US11634423B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:01:13 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US11634423B23 |
| Notes | Application Number: US202117168399 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230425&DB=EPODOC&CC=US&NR=11634423B2 |
| ParticipantIDs | epo_espacenet_US11634423B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20230425 |
| PublicationDateYYYYMMDD | 2023-04-25 |
| PublicationDate_xml | – month: 04 year: 2023 text: 20230425 day: 25 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Eli Lilly and Company |
| RelatedCompanies_xml | – name: Eli Lilly and Company |
| Score | 3.4618285 |
| Snippet | The present invention provides a compound of Formula I:wherein R isor a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230425&DB=EPODOC&locale=&CC=US&NR=11634423B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFfVNq2LrwQqSJ4NujrZ5CEKSliL2wLZSECmbZBcjmJQkIvrrnV1b64u-7QHL7sA3MzsnwAW_tpUirwuTCt2yGNNDK-K6EcWCcoPyprJD9gfN3tS6ndmzCryscmFUndB3VRwRERUh3kvFrxdrI1agYiuLqzDBpeymO3EDbfk7lhZOw9YCz-2MhsHQ13zfnY61wb1LUe-wUHXwkF1voBrdkmjoPHgyK2XxW6R0d2FzhKel5R5UeFqDbX_Vea0GW_2lwxuHS-wV-3AnMf7t2I_J4iNnn8i3HumlrbMnnCavSSxD2AkrSJI-J2Ei--iQTBBZESIXPM9SIqM1mExAP4Dzbmfi93S81vyHBvPpeP0C8xCqaZbyIyCx0zap2eRxS1bVEdyhLKZt7gjHZG1uturQ-Pucxn-bx7Aj6SkdJ4Z9AtUyf-OnKH_L8EwR7gv2SYuH |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFeubVkXrtYLkyaCbo20egtCkpWovbCsFkbBpdjGCSUkjor_e2bW1vujbHrDsDnwzs3MCnPMrWynyujCp0C2LMT20plw3ppGg3KC8quyQ3V61PbZuJ_akAC_LXBhVJ_RdFUdERE0R77ni17OVEctXsZXzyzDGpfS6NXJ9bfE7lhZOw9b8htsc9P2-p3meOx5qvXuXot5hoerQQHa9hip2TaKh-dCQWSmz3yKltQXrAzwtybehwJMylLxl57UybHQXDm8cLrA334GOxPi3Yz8is4-MfSLfeqQXts6ecBq_xpEMYSdsTuLkOQ5j2UeHpILIihCZ4FmaEBmtwWQC-i6ctZojr63jtYIfGgTj4eoF5h4UkzTh-0Aip25Ss8qjmqyqI7hDWUTr3BGOyercrB1A5e9zKv9tnkKpPep2gs5N7-4QNiVtpRPFsI-gmGdv_BhlcR6eKCJ-Aa19jno |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+pyrazolo%5B1%2C5-a%5Dpyrimidines+as+inhibitors+of+interferon+signaling&rft.inventor=Jessop%2C+Theodore+Curtis&rft.inventor=Chen%2C+Zhaogen&rft.inventor=Bleisch%2C+Thomas+John&rft.date=2023-04-25&rft.externalDBID=B2&rft.externalDocID=US11634423B2 |